CeriBell Inc. (CBLL)
20.23
-0.82 (-3.90%)
At close: Mar 25, 2025, 3:59 PM
-3.90% (1D)
| Bid | 20.04 |
| Market Cap | 725.62M |
| Revenue (ttm) | 75.22M |
| Net Income (ttm) | -46.5M |
| EPS (ttm) | -3.39 |
| PE Ratio (ttm) | -5.97 |
| Forward PE | -19.83 |
| Analyst | Buy |
| Ask | 20.33 |
| Volume | 68,367 |
| Avg. Volume (20D) | 191,411 |
| Open | 21.24 |
| Previous Close | 21.05 |
| Day's Range | 20.05 - 20.88 |
| 52-Week Range | 18.69 - 32.75 |
| Beta | 1.39 |
About CBLL
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its nam...
Industry Medical - Devices
Sector Healthcare
IPO Date n/a
Employees 281
Stock Exchange NASDAQ
Ticker Symbol CBLL
Website https://ceribell.com
Analyst Forecast
According to 5 analyst ratings, the average rating for CBLL stock is "Buy." The 12-month stock price forecast is $32.5, which is an increase of 60.65% from the latest price.
Stock Forecasts
